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Multiple myeloma 
presenting with lower 
extremity gangrene and 
hyperviscosity syndrome
ABSTRACT
Hyperviscosity syndrome and cryoblobulinemia associated with lymphoproliferative disorder is a rare but life threatening 
condition. The delay of diagnosis can lead to severe mutilation and multiple organ damage. The plasma exchange thera-
py and the targeted treatment of the underlying disorder can lead to significant improvement. We present a patient who 
developed extensive soft tissue necroses, mimicking the peripheral artery disease. Despite surgical treatment, the skin 
lesions progressed involving fingers, earlobes and scrotum. Finally, the patient was diagnosed with multiple myeloma and 
hyperviscosity syndrome. The clinical condition improved after plasma exchange and myeloma treatment with thalidomide 
and dexamethasone.
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Introduction
The extensive lower limb gangrene 
appearing in the absence of diabetes 
mellitus or systemic atherosclerosis is 
a rare condition. Differential diagnosis 
includes systemic infective diseases, 
connective tissue diseases, vasculiti-
des or metabolic disorders. (1,2) The 
aim of this paper is to present a patient 
who developed extensive soft tissue 
necrosis as the first manifestation of 
IgG kappa multiple myeloma associ-
ated with cryoglobulinemia (CG) and 
hyperviscosity syndrome. 
Case presentation
A fifty-year old man with a history of 
smoking, alcohol abuse and significant 
weight loss (20 kg) over the period of 
10 months presented with skin and 
soft tissue necrosis of the foot, deve-
loping after a minor injury of the leg. 
Computerized tomography (CT) of the 
aorta, pelvis and legs did not reveal 
any significant lesions of the major arte-
ries, but the flow obstruction distal to 
the posterior tibial artery was descri-
bed. The transmetatarsal amputation 
of the right foot was performed. Soon 
after the amputation, gangrene of the 
remaining foot, fingers, ears and penis 
developed, requiring the transmeta-
tarsal amputation of another foot. The 
patient became lethargic and febrile 
and was transferred from the regional 
hospital to the University Hospital Cen-
tre Zagreb Medical Intensive Care Unit. 
At admission, his GCS was 8, axillary 
temperature was 38˚C with radiograp-
hic signs of pneumonia. Necrotic skin 
lesions were present on the earlobes, 
hands, scrotum, fingers, with large 
necrotic areas on both legs (figure 1). 
Femoral and popliteal arterial blood 
flow was sonographically detectable. 
Laboratory tests showed anemia, renal 
lesion, hypercalcemia, coagulopathy 
and extremely elevated total protein 
level (table 1). Electrophoresis of serum 
proteins with immunofixation detec-
ted monoclonal IgG kappa (free light 
chain IgG kappa 1900.00 g/L (ref 3.30 
– 19.40), Ig lambda <1.73 (ref 5.71-
26.30). Cryoglobulin was identified in 
the patient’s serum (serum precipitated 
at 4˚C), but cryoglobulin electrophore-
sis was not performed due to technical 
issues. Bone marrow was infiltrated 
with 60-90% plasma cells. Skeletal sur-
veys revealed punched-out lytic lesions 
of the vertebrae, skull, thoracic cage, 
pelvis, humeri, femora and tibia. A skin 
biopsy showed no sign of vasculitis. 
Diagnosis of multiple myeloma IgG 
kappa was made and treatment was 
started immediately. 
Plasma exchange with 5% albumin 
substitution was started on the day of 
admission for hyperproteinemia, cryo-
globulinemia and hyperviscosity syn-
drome (the viscosity of plasma was not 
measured). The patient became oligulic 
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and progressively hypoxaemic, requ-
iring mechanical ventilation and renal 
replacement therapy. 
Multiple myeloma treatment with dex-
amethasone and thalidomide was start-
ed on the third day following admis-
sion. The patient received a single dose 
of pamidronate for hypercalcemia. 
Besides hyperviscosity syndrome, and 
possible cryoglobulinemia, no other 
reason for vascular insufficiency was 
found. 
In total, 5 plasma exchange procedures 
were performed. The patient gradually 
improved with treatment. He regained 
consciousness, regression and healing 
of skin necrotic lesions occurred. His 
respiratory status improved, allowing 
for the termination of mechanical ven-
tilation. Serum creatinine decreased 
and diuresis recovered up to 2000 ml 
daily without renal replacement thera-
py. Cryoglobulins could no longer be 
detected. The patient was transferred to 
a regional hospital and the continuance 
of treatment with borthesomybe was 
planned. Unfortunately, following the 
transfer, the patient developed another 
septic episode with fatal outcome. 
Discussion 
Peripheral artery disease is the most 
common cause of lower limb soft tis-
sue disorders. (1) The patient’s initial 
presentation with lower extremity gan-
grene, together with age and history 
of tobacco abuse, indicated athero-
sclerotic arterial ischemia of the lower 
limb. However, there were no signs of 
ischemia on other vascular beds (myo-
cardial infarction or cerebrovascular 
insult) and CT arteriography showed 
no signs of atherosclerotic arterial dis-
ease (vessel wall calcification, multives-
sel involvement, a mixture of focal and 
diffuse lesions, or typical ostial and 
proximal artery locations). (1) The dif-
ferential diagnosis of peripheral tissue 
necrosis, the absence of major arterial 
obstruction or diabetes mellitus is wide 
and includes vaculitides such as pol-
yarteritis nodosa, connective tissue dis-
eases (such as Sjogren’s Syndrome), 
systemic lupus erythematosus, pyoder-
ma gangrenosum, infective diseases 
(such as necrotizing fasciitis), and sep-
tic embolism. (2) In patients with end 
stage renal disease, skin and soft tissue 
necrosis can rarely appear as a result of 
calciphylaxis. (2) Skin biopsy, however, 
revealed only thrombotic occlusions of 
small vessels without signs of vasculi-
tis. Multiple myeloma and associated 
hyperviscosity syndrome were diag-
nosed based on clinical presentation 
and laboratory results. (3) 
Multiple myeloma is a plasma cell 
neoplasm that is characterized by a 
single clone of plasma cells produc-
ing a monoclonal protein (M-protein). 
Malignant proliferation of plasma cells 
produces skeletal destruction, causing 
bone pain and pathologic fractures. 
(3) It accounts for 10% of all hemato-
logic malignancies. Diagnostic criteria 
include the presence of M-protein in 
serum and/or urine, presence of 10% 
or more clonal bone marrow plasma 
cells and related organ or tissue impair-
ment (such as hypercalcemia, renal 
insufficiency, anemia, and lytic bone 
lesions on radiographic survey). All of 
the diagnostic criteria were met in our 
patient. The M-protein might also lead 
to hyperviscosity syndrome or recurrent 
infections through the suppression of 
normal immunoglobulins. 
Cryoglobulinemia is a rare condition, 
accompanying a broad spectrum of 
different states and diseases, which 
is manifested by palpable purpura, 
progressing to skin and soft tissue 
necrosis, arthralgia and myalgia. Cry-
oglobulin consists of immunoglobu-
lins and complement components 
and precipitates upon refrigeration of 
serum and plasma. Mixed or polyclo-
nal cryoglobulins (type II and III) can 
be seen in patients with autoimmune 
disorders, chronic infections (particu-
larly hepatitis C virus and HIV infec-
tion), and lymphoproliferative disorders. 
Monoclonal cryoglobulin (type I) are 
often revealed in patients with multiple 
myeloma or Waldenström’s macroglob-
ulinemia. (4) Clinical symptoms results 
from cryoglobulinemic organ damage, 
produced by autoimmune-mediated 
vasculitis or accumulation of cryoglobu-
lins and obstruction of small vessels. 
The prevalence of clinically-significant 
cryoglobulinemia has been estimated 
at approximately 1 in 100,000, and type 
I CG accounts for 5-25% of all clinical 
cases. (5) Type I CG classically produc-
es signs related to hyperviscosity and/
or thrombosis: Raynaud phenomenon, 
digital ischemia, livedo reticularis, and 
purpura may occur. In severe cases, 
and without treatment, this may progress 
to gangrene. Neurologic symptoms of 
Picture1.  The extensive lower limb skin necroses present at admission to 
medical intensive care unit.
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hyperviscosity include blurring or loss of 
vision, headache, vertigo, sudden deaf-
ness, diplopia, ataxia, confusion, and 
disturbances of consciousness. (5)
Clinically significant type I CG associ-
ated with multiple myeloma is sporadi-
cally reported in literature in the form 
of isolated care reports or small ret-
rospective studies, and general treat-
ment recommendations include the 
treatment of the underlying lymphopro-
liferative disease. (6,7) A French retro-
spective study over a 15-year period 
identified 64 patients with symptomatic 
type I CG. (8) All patients had either 
a hematologic malignancy or mono-
clonal gammapathy of unknown sig-
nificance. Cutaneous involvement was 
often present, renal disease was seen 
in 30% of patients. None of the patients 
exhibited central nervous system mani-
festations. Treatment included gluco-
corticoids, plasma exchange, alkylating 
agents, rituximab, and other chemo-
therapy; 10% of patients did not require 
treatment. Ten-year survival was 87%, 
with poorer survival rates in patients 
with hematologic malignancy. Another 
report from a series of 7 patients with 
symptomatic type I CG and multiple 
myeloma noted the benefit of therapies 
that included drug regimens directed at 
the myeloma. (9) 
Our patient initially presented only lower 
extremity skin lesions, more severe and 
progressive than usually associated 
with hyperviscosity syndrome. Serum 
hyperviscosity, hypercalcemia, concur-
rent sepsis and dehydration all contrib-
uted to the renal dysfunction, neurologi-
cal symptoms and respiratory distress. 
Daily plasma exchange, accompanied 
by glucocorticoids and thalydomide 
as a targeted treatment of multiple 
myeloma led to a remarkable clinical 
response, recovery of diuresis, normali-
zation of serum protein level and the 
disappearance of cryoglobulins. 
Conclusion
Hyperviscosity syndrome and cryoblo-
bulinemia associated with lymphoproli-
ferative disorder is a rare but life threa-
tening condition. The delay of diagnosis 
can lead to severe mutilation and mul-
tiple organ damage. The plasma exc-
hange therapy and targeted treatment 
of the underlying disorder can lead to 
significant improvement.
Table 1. Laboratory values at admission to medical intensive care unit. 
Variable Reference range Measured value
ESR 5-28 mm/h 130
Hemoglobin 119 – 157 (g/L) 78
Lukocytes 3.4 – 9.7 (x109/L) 4.75
Thrombocytes 158 – 424 (x109/L) 175
Prothrombin time > 0.70 (s) 0.45
D-dimer < 0.5 (mg/L) 1.52
fibrinogen 1.8 – 4.1 (mg/L) 2.8
creatinine 63 – 107 (umol/L) 221 
BUN 2.8 – 8.3 (umol/L) 12.5
Na 137 – 146 (umol/L) 139
K 3.9 – 5.1 (umol/L) 3.0
Ca++ 2.14 – 2.53 (umol/L) 2.83
Total serum proteins 66 – 81 g/L 99
BUN, blood urea nitrogen; ESR, erithrocyte sedimentation rate
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